Highlights of Past EHA (HOPE) Cairo 2018

EHA is returning to Cairo with the 3rd edition of the Highlights of Past EHA (HOPE). The meeting is organized in partnership with regional and national societies in the Middle East and North Africa.

Dates: September 27-29, 2018
Location: Cairo, Egypt

Prof Pieter Sonneveld, President, European Hematology Association (EHA)
Prof John Gribben, President-elect, European Hematology Association (EHA)
Prof Mohamad Qari, President, Pan Arab Hematology Association (PAHA)
Prof Mervat Mattar, Vice President, Pan Arab Hematology Association (PAHA)
Prof Amal El-Beshlawy, Vice President, Egyptian Society of Hematology and Research (ESHR)
Prof Azza Kamel, Secretary General, Egyptian Society of Hematology and Research (ESHR)

Online registration is now open. Special fees are available for juniors and regional attendees. Register now

HOPE Cairo 2018 aims to bring the key messages from various fields of hematology of the 23rd Congress of EHA to the Middle East and North Africa. As such, the meeting will provide a summary of the most important education and scientific sessions of the EHA Congress tailored to the needs of the local hematologist.

Meeting objectives

Participants of HOPE Cairo 2018 will be able to:

  • enhance their knowledge of evidence-based approaches on diagnosis and treatment for hematologic diseases,
  • access the latest results on clinical and translational research in hematologic disorders,
  • be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in hematology and its subspecialties, and
  • communicate, collaborate and network with colleagues and representatives of a large international audience from the medical industry.

Program and abstract submission

The HOPE Cairo 2018 program covers a variety of topics from the 23rd Congress of EHA by key leaders in their fields. It will include sessions on:

  • Acute leukemias
  • Chronic lymphocytic leukemia
  • Hodgkin lymphoma
  • Laboratory hematology
  • Multiple myeloma
  • Pediatric hematology
  • Thalassemia, anemia, sickle cell disease and red cells
  • Thrombosis and hemostasis

For the full meeting program, click here.

In addition, regional hematologists had the opportunity to submit abstracts for inclusion in the program. Selected abstracts will be presented as posters and will be discussed with attendees and faculty. The corresponding authors will be informed of the allocation results by August 15, 2018. For more information, click here.

Target audience

Physicians, clinicians, basic researchers, biologists, trainees, medical students and pharmaceutical companies in the Middle East and North Africa interested in the broad field of hematology, specifically those who could not attend the 23rd Congress of EHA.


Click here to visit the registration page for more information.


The European Hematology Association will provide scholarships to junior doctors and students to support them in attending HOPE Cairo 2018. Click here for more information.


The meeting will take place in the Hilton Cairo Heliopolis:
El-Orouba, Qism El-Nozha, Cairo Governate 2466
Cairo, Egypt
Tel: +20-2-22677730
Fax: +20-2-22677600

Key dates

Partner acknowledgment

EHA would like to thank the following regional and national partners for their collaboration. This supports us in realizing our educational goal of bringing the key messages from various fields of hematology of the 23rd Congress of EHA to the Middle East and North Africa which contributes to the advancement of hematology education and science in the region:

Partners HOPE2

Sponsor acknowledgment

This meeting is supported by:

Major level partner

Janssen logo

Sponsorship opportunities

Would you like to join our list of sponsors, please visit  this page.

EBAH CME Accreditation

EBAH accredited stamp DEF2Highlights of Past EHA (HOPE) is accredited by the European Board for Accreditation in Hematology (EBAH) CME. EBAH CME is the best way for hematologists to master the latest developments within the specialty of hematology. Staying abreast of these scientific developments and keeping in touch with up-to-date views on clinical policy will enable you to raise your professional level, resulting in the best treatment for your patients.